These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6628547

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Dependence of the effects of tripeptide MIF and lithium chloride on the degree of supersensitivity of dopamine receptors of the brain].
    Bondarenko NA, Val'dman AV.
    Biull Eksp Biol Med; 1989 Aug; 108(8):196-9. PubMed ID: 2553154
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC, Delini-Stula AA.
    Eur J Pharmacol; 1979 May 15; 55(4):363-73. PubMed ID: 572774
    [Abstract] [Full Text] [Related]

  • 25. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats.
    Hernandez L, Baptista T, Hoebel BG.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 May 15; 14 Suppl():S17-35. PubMed ID: 2097671
    [Abstract] [Full Text] [Related]

  • 26. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM.
    Eur J Pharmacol; 1980 Jun 13; 64(2-3):123-32. PubMed ID: 6105080
    [Abstract] [Full Text] [Related]

  • 27. Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat.
    Fage D, Guerin B, Feuerstein C, Demenge P, Scatton B.
    Brain Res; 1984 Sep 24; 310(2):379-83. PubMed ID: 6488029
    [Abstract] [Full Text] [Related]

  • 28. Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivity.
    Scatton B, Fage D, Oblin A, Zivkovic B, Arbilla S, Langer SZ, Bartholini G.
    Psychopharmacology Suppl; 1985 Sep 24; 2():39-45. PubMed ID: 2987906
    [Abstract] [Full Text] [Related]

  • 29. The effect of chronic lithium administration on dopamine metabolism in rat striatum.
    Hesketh JE, Nicolaou NM, Arbuthnott GW, Wright AK.
    Psychopharmacology (Berl); 1978 Mar 01; 56(2):163-6. PubMed ID: 25454
    [Abstract] [Full Text] [Related]

  • 30. Effects of piracetam on the central dopaminergic transmission.
    Rägo LK, Allikmets LH, Zarkovsky AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec 01; 318(1):36-7. PubMed ID: 6276786
    [Abstract] [Full Text] [Related]

  • 31. Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain.
    Reches A, Wagner HR, Jackson V, Fahn S.
    Brain Res; 1982 Aug 19; 246(1):172-7. PubMed ID: 6289974
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.
    Meller E, Friedhoff AJ, Friedman E.
    Life Sci; 1980 Feb 18; 26(7):541-7. PubMed ID: 7366335
    [No Abstract] [Full Text] [Related]

  • 34. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Rajakumar G, Naas F, Johnson RL, Chiu S, Yu KL, Mishra RK.
    Peptides; 1987 Feb 18; 8(5):855-61. PubMed ID: 2893360
    [Abstract] [Full Text] [Related]

  • 35. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K, Ogawa K, Noma S, Kameyama T.
    J Pharmacobiodyn; 1986 Jan 18; 9(1):88-94. PubMed ID: 3712211
    [Abstract] [Full Text] [Related]

  • 36. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P, Nosé P, Gordon EK, Lovenberg W.
    Science; 1977 Jul 08; 197(4299):181-3. PubMed ID: 17917
    [Abstract] [Full Text] [Related]

  • 37. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL, Kilpatrick IC.
    Br J Pharmacol; 1996 May 08; 118(2):421-7. PubMed ID: 8735647
    [Abstract] [Full Text] [Related]

  • 38. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M, Sjöholm B, Lappalainen J, Virtanen R.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):321-4. PubMed ID: 2530097
    [Abstract] [Full Text] [Related]

  • 39. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH, Korf J.
    Eur J Pharmacol; 1976 Nov 10; 40(1):131-6. PubMed ID: 991922
    [Abstract] [Full Text] [Related]

  • 40. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.
    Kashihara K, Sato M, Fujiwara Y, Harada T, Ogawa T, Otsuki S.
    Biol Psychiatry; 1986 Jun 10; 21(7):650-6. PubMed ID: 3011131
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.